336 related articles for article (PubMed ID: 15565331)
1. [18F]FLT-PET in oncology: current status and opportunities.
Been LB; Suurmeijer AJ; Cobben DC; Jager PL; Hoekstra HJ; Elsinga PH
Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1659-72. PubMed ID: 15565331
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT
J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
[TBL] [Abstract][Full Text] [Related]
3. [Is 3'-deoxy-3'- [18F] fluorothymidine ([18F]-FLT) the next tracer for routine clinical PET after R [18F]-FDG?].
Couturier O; Leost F; Campone M; Carlier T; Chatal JF; Hustinx R
Bull Cancer; 2005 Sep; 92(9):789-98. PubMed ID: 16203269
[TBL] [Abstract][Full Text] [Related]
4. Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?
Cobben DC; Elsinga PH; Hoekstra HJ; Suurmeijer AJ; Vaalburg W; Maas B; Jager PL; Groen HM
J Nucl Med; 2004 Oct; 45(10):1677-82. PubMed ID: 15471832
[TBL] [Abstract][Full Text] [Related]
5. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
[TBL] [Abstract][Full Text] [Related]
6. 18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.
Giammarile F; Billotey C; Lombard-Bohas C; Le Bars D; Bournaud C; Masson S; Walter T; Houzard C; Scoazec JY; Hervieu V; Vuillez JP; Cornu C; Janier M; Borson-Chazot F
Nucl Med Commun; 2011 Feb; 32(2):91-7. PubMed ID: 21076344
[TBL] [Abstract][Full Text] [Related]
7. A systematic review on [(18)F]FLT-PET uptake as a measure of treatment response in cancer patients.
Bollineni VR; Kramer GM; Jansma EP; Liu Y; Oyen WJ
Eur J Cancer; 2016 Mar; 55():81-97. PubMed ID: 26820682
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.
Buck AK; Herrmann K; Shen C; Dechow T; Schwaiger M; Wester HJ
Methods; 2009 Jun; 48(2):205-15. PubMed ID: 19318128
[TBL] [Abstract][Full Text] [Related]
9. 3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose.
Yamamoto Y; Nishiyama Y; Ishikawa S; Gotoh M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
J Comput Assist Tomogr; 2008; 32(3):432-7. PubMed ID: 18520552
[TBL] [Abstract][Full Text] [Related]
10. Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.
Waldherr C; Mellinghoff IK; Tran C; Halpern BS; Rozengurt N; Safaei A; Weber WA; Stout D; Satyamurthy N; Barrio J; Phelps ME; Silverman DH; Sawyers CL; Czernin J
J Nucl Med; 2005 Jan; 46(1):114-20. PubMed ID: 15632041
[TBL] [Abstract][Full Text] [Related]
11. Imaging proliferation in human leukemia-tumor bearing mice with (18)F-FLT: Comparison with (18)F-FDG PET.
Lu L; Jiang L; Guan H; Gao Y; Lu H
Hell J Nucl Med; 2012; 15(3):206-9. PubMed ID: 23106052
[TBL] [Abstract][Full Text] [Related]
12. FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine.
Salskov A; Tammisetti VS; Grierson J; Vesselle H
Semin Nucl Med; 2007 Nov; 37(6):429-39. PubMed ID: 17920350
[TBL] [Abstract][Full Text] [Related]
13. Visualisation of neuroblastoma growth in a Scid mouse model using [18F]FDG and [18F]FLT-PET.
Krieger-Hinck N; Gustke H; Valentiner U; Mikecz P; Buchert R; Mester J; Schumacher U
Anticancer Res; 2006; 26(5A):3467-72. PubMed ID: 17094468
[TBL] [Abstract][Full Text] [Related]
14. [18F]FLT PET for diagnosis and staging of thoracic tumours.
Dittmann H; Dohmen BM; Paulsen F; Eichhorn K; Eschmann SM; Horger M; Wehrmann M; Machulla HJ; Bares R
Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1407-12. PubMed ID: 12898201
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of imaging proliferative activity in lung nodules.
Buck AK; Hetzel M; Schirrmeister H; Halter G; Möller P; Kratochwil C; Wahl A; Glatting G; Mottaghy FM; Mattfeldt T; Neumaier B; Reske SN
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):525-33. PubMed ID: 15599526
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of positron emission tomographic tracers for imaging of papillomavirus-induced tumors in rabbits.
Probst S; Wiehr S; Mantlik F; Schmidt H; Kolb A; Münch P; Delcuratolo M; Stubenrauch F; Pichler BJ; Iftner T
Mol Imaging; 2014; 13():. PubMed ID: 24622808
[TBL] [Abstract][Full Text] [Related]
17. Current clinical status of
Nakajo M; Kajiya Y; Jinguji M; Nakabeppu Y; Nakajo M; Nihara T; Yoshiura T
Abdom Radiol (NY); 2017 Mar; 42(3):951-961. PubMed ID: 27770160
[TBL] [Abstract][Full Text] [Related]
18. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
19. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.
Choi SJ; Kim JS; Kim JH; Oh SJ; Lee JG; Kim CJ; Ra YS; Yeo JS; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):653-9. PubMed ID: 15711980
[TBL] [Abstract][Full Text] [Related]
20. Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.
Kameyama R; Yamamoto Y; Izuishi K; Takebayashi R; Hagiike M; Murota M; Kaji M; Haba R; Nishiyama Y
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):382-8. PubMed ID: 18985344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]